IP Library › Granted Patent US 10,689,689
Granted Patent B2
US 10,689,689 · App. 15/385,468 · Granted Jun 23, 2020

Generic method for the stabilization of specific RNA

Inventor: Amar Gupta (Danville, CA)
Assignee: Roche Molecular Systems, Inc.
C12Q1/6832C12Q1/6848C12Q1/6851C12Q1/6853C12Q1/6876
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,689,689
App. No.
15/385,468
Granted
Jun 23, 2020
Kind
B2
Abstract

The present invention relates to methods and compositions for the stabilization of specific RNA molecules that can either be the target for detection or the control standard.

Claims (6)

1. A method of preventing or reducing degradation of a segment of a single-stranded RNA template that is amplified in an amplification reaction, the method comprising the steps of:

a) providing the single-stranded RNA template;

b) hybridizing the segment of the single-stranded RNA template with one or more oligonucleotides whose sequences are completely or partially complementary to the segment of the single-stranded RNA template that is amplified; and

c) reverse transcribing and amplifying the segment of the single-stranded RNA template under reaction conditions whereby the one or more oligonudeotides do not interfere with reverse transcription and amplification and whereby each one oligonucleotide from the one or more oligonucleotides is characterized by both being between 11 nucleotides and 50 nucleotides in length and having a melting temperature that is at least 5° C. lower than an extension temperature used during amplification, and wherein the sequence of each one oligonudeotide from the one or more oligonudeotides does not overlap with the sequence of another oligonudeotide from the one or more oligonudeotides; and

the one or more oligonucleotides are present at a concentration that is at least fifty-fold lower than concentrations of primers and probes used during reverse transcription and amplification;

wherein the one or more oligonudeotides comprise a group of oligonudeotides whose sequences consist of SEQ ID NOs: 1-10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2020
From: GUPTA, AMAR
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 052367/0037 →
Continuity (2)
Provisional Application 62271614 · Dec 28, 2015
Related Publication 20170183720A1 · Jun 29, 2017